首页> 外文会议>World biomaterials congress >Pericyte-based collagen scaffold for vascular tissue engineering
【24h】

Pericyte-based collagen scaffold for vascular tissue engineering

机译:基于周细胞的胶原蛋白支架,用于血管组织工程

获取原文

摘要

Pericytes are a perivascular cell population embedded on the capillary wall in a shared basement membrane with the endothelium. During vasculogenesis and angiogenesis, endothelial cells secrete and/or present cell bound molecular cues that stimulate pericytes to proliferate, migrate and attach to nascent capillary tubes. It has been previously developed cell sheet engineering using temperature-responsive culture dishes in order to avoid traditional tissue engineering approaches. In this study our aim is to isolate human umbilical cord vein pericytes then differentiate into smooth muscle cells and fibroblasts then co-culture these cells on 3D collagen scaffold that will be used for generating tissue engineering vascular grafts. Pericytes were enzymatically isolated from human umbilical cord vein and were purified by using MACs cell separation with CD146 microbeads. They were cultured in fibroblast growth medium and smooth muscle growth medium for 21 days on poly(N-isopropylacrylamide) to obtain cell sheets. Cell differentiation was confirmed by immunofluorescence staining and flow cytometry analysis (fibroblast markers; Tenascin-C and Collagen type Ⅰ, smooth muscle cell markers; Caldesmon, Calponin and Alpha smooth muscle actin). Collagen gel was prepared with human collagen type Ⅰ (3mg/mL) + 10X DMEM (adjustment pH of mixture to 7.2-7.6 using sterile 0.1 M NaOH). Collagen gel was covered by cell sheets (sandwich system) and vascular graft was incubated in 37oC for 7 days (Figure 1). The results indicated that perivascular cells could differentiate into fibroblast and smooth muscle and formed vascular graft with collagen gel. As a conclusion, differentiated pericytes offer an alternative cell source for constructing tissue engineered vascular graft. The authors wish to thank The Scientific and Technological Research Council of Turkey (Project Number 113S815) for their financial support.
机译:周细胞是与内皮共享的基底膜中包埋在毛细血管壁上的血管周细胞群。在血管生成和血管生成过程中,内皮细胞分泌和/或呈现细胞结合的分子线索,这些分子线索刺激周细胞增殖,迁移并附着在新生毛细管上。为了避免传统的组织工程方法,以前已经开发了使用温度响应性培养皿的细胞片工程技术。在这项研究中,我们的目标是分离人脐带静脉周细胞,然后分化为平滑肌细胞和成纤维细胞,然后在3D胶原蛋白支架上共同培养这些细胞,这些支架将用于生成组织工程性血管移植物。从人的脐带静脉中酶分离过周细胞,并通过使用具有CD146微珠的MACs细胞分离来纯化周细胞。将它们在成纤维细胞生长培养基和平滑肌生长培养基中在聚(N-异丙基丙烯酰胺)上培养21天以获得细胞片。通过免疫荧光染色和流式细胞仪分析(成纤维细胞标志物;腱生蛋白-C和Ⅰ型胶原;平滑肌细胞标志物;卡尔德斯蒙,钙蛋白和Alpha平滑肌肌动蛋白)确认了细胞分化。用人Ⅰ型胶原蛋白(3mg / mL)+ 10X DMEM(用无菌0.1 M NaOH将混合物的pH调节至7.2-7.6)制备胶原蛋白凝胶。胶原蛋白凝胶被细胞片覆盖(三明治系统),血管移植物在37oC下孵育7天(图1)。结果表明,血管周细胞可以分化为成纤维细胞和平滑肌,并与胶原蛋白凝胶形成血管移植物。结论是,分化的周细胞为构建组织工程化的血管移植物提供了另一种细胞来源。作者要感谢土耳其科学技术研究委员会(项目编号113S815)的财政支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号